C, S., & M, G. (2023). Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design. Molecular pharmaceutics, 20(3), 1453. https://doi.org/10.1021/acs.molpharmaceut.2c01027
Chicago Style (17th ed.) CitationC, Sumithaa, and Ganeshpandian M. "Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design." Molecular Pharmaceutics 20, no. 3 (2023): 1453. https://doi.org/10.1021/acs.molpharmaceut.2c01027.
MLA (9th ed.) CitationC, Sumithaa, and Ganeshpandian M. "Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design." Molecular Pharmaceutics, vol. 20, no. 3, 2023, p. 1453, https://doi.org/10.1021/acs.molpharmaceut.2c01027.